Dr. Daniel Talmasov, MD

Dr. Talmasov practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Talmasov's NPI, 1023402245, was assigned on March 25, 2015. Dr. Talmasov holds New York license 297109-1.

Dr. Talmasov's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Talmasov's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Talmasov is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Talmasov to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Talmasov practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Talmasov's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Talmasov is licensed in New York.

CMS data shows 19 Medicare services from Dr. Talmasov across 1 procedure code in 2024, for 15 Medicare patients. Medicare paid $257 for them. Every service was in an office.

CMS counts 15 Medicare patients who saw Dr. Talmasov in 2024. The largest group is under 65, with 0 patients. 75% of them have alzheimer's and dementia. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Talmasov's median patient age at 76, with 50% women.

In 2024, Dr. Talmasov wrote 92 Medicare Part D claims for 20 patients. 87% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $477 in total drug cost. In 2023, CMS named 58 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Talmasov for performance year 2024, reported through an alternative payment model (APM). Dr. Talmasov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Talmasov as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Talmasov from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $97.